Company Analysis

Stevanato Group S.p.A. (STVN)

NYSE: STVN · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2021
Grade5.5
◀ Past 7.5● Present 5.6▶ Future 3.3
1 est.

Who runs Stevanato Group S.p.A.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Stevanato Franco
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
3
of 13 people with a filing in the last fifteen months
Directors reporting now
10
13 people on the record since 2026
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Stocchi MauroChief Business Strategy OfficerMar 2026Sep 30, 20261 · $300,000
Dal Lago MarcoChief Financial OfficerMar 2026Aug 10, 20261 · $100,000
Stevanato FrancoChief Executive OfficerMar 2026Mar 18, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Federici William JdirectorMar 2026Nov 12, 20261 · $0.00
Morel Donald E JrdirectorMar 2026Nov 10, 20261 · $0.00
Magistretti ElisabettadirectorMar 2026Aug 10, 20261 · $0.00
Santel LucianodirectorMar 2026Aug 10, 20261 · $0.00
Balachandran MadhavandirectorMar 2026Jun 26, 20261 · $0.00
Flynn KarendirectorMar 2026Jun 26, 20261 · $0.00
Lin Sue-JeandirectorMar 2026Jun 26, 2026none
Bonanni FabriziodirectorMar 2026Mar 18, 2026none
Spinazzi AlvisedirectorMar 2026Mar 18, 2026none
Stevanato SergiodirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton STVN · research, not advice